Thomas GRUB

Thomas Grub is a Senior Expert for Global Pricing & Market Access at Medac in Wedel, Germany. He leads international market access projects with a focus on value added medicines and innovative access models. Thomas represents Medac and Oncomed in several working groups within Medicines for Europe Value Added Medicines Sector and EUCOPE, and contributes to the WHO Europe “Novell Medicines” platform.
Before taking on his current role, he established Medac’s global Market Access & Health Economics function, which was evaluating international development and in‑licensing opportunities with regard to pricing, reimbursement, reference pricing, and parallel trade dynamics. Earlier, he led international medical and scientific marketing, managed product teams and portfolios, and worked across therapeutic areas including rheumatology, psoriasis, oncology, neurosurgery, and urology.
Thomas began his career in sales and product management across multiple pharmaceutical companies, where he successfully launched products, drove strong market share growth, and positioned brands in competitive environments.
He studied Chemistry at the University of Kaiserslautern and earned his PhD in Organic Chemistry in 1996.